Harmony Biosciences

Read more
John C Jacobs's photo - President & CEO of Harmony Biosciences

President & CEO

John C Jacobs

CEO Approval Rating

90/100

Founded:

2017

Status:

PublicIndependent CompanyNASDAQHRMY

HARMONY BIOSCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Harmony Biosciences's company profile
John C Jacobs's photo - President & CEO of Harmony Biosciences

John C Jacobs

President & CEO

90/100
150
$673.4M
$235.4M
View Profile
1
Harmony Biosciences's Competitor - sunosi logo
CEO Avatar

CEO

- -
- -
View Profile
2
Harmony Biosciences's Competitor - Provigil logo
CEO Avatar

CEO

- -
- -
View Profile
3
Harmony Biosciences's Competitor - NUVIGIL logo
CEO Avatar

CEO

- -
10
- -
$10M
View Profile
4
Harmony Biosciences's Competitor - Caladrius logo
David J. Mazzo's photo - President & CEO of Caladrius

David J. Mazzo

President & CEO

92/100
25
$169.3M
$16M
View Profile
5
Harmony Biosciences's Competitor - Amicus logo
John F. Crowley's photo - Chairman & CEO of Amicus

John F. Crowley

Chairman & CEO

84/100
508
$842.6M
$281.8M
View Profile
6
Harmony Biosciences's Competitor - RegeneRx logo
J.J Finkelstein's photo - President & CEO of RegeneRx

J.J Finkelstein

President & CEO

88/100
3
$9.2M
$ < 1M
View Profile
7
Harmony Biosciences's Competitor - Fibrocell logo
John Maslowski's photo - President & CEO of Fibrocell

John Maslowski

President & CEO

82/100
19
$116.9M
$23.1M
View Profile
8
Harmony Biosciences's Competitor - Lanthio Pharma logo
Gert Moll's photo - Managing Director of Lanthio Pharma

Gert Moll

Managing Director

77/100
74
- -
$5M
View Profile
9
Harmony Biosciences's Competitor - viDA logo
Alistair Duncan's photo - President & CEO of viDA

Alistair Duncan

President & CEO

79/100
40
$8.1M
$7M
View Profile
10
Harmony Biosciences's Competitor - Sanofi logo
Paul Hudson's photo - CEO of Sanofi

Paul Hudson

CEO

74/100
99,412
- -
$45.6B
View Profile
11
Harmony Biosciences's Competitor - Cesca logo
Chris Xu's photo - Chairman & CEO of Cesca

Chris Xu

Chairman & CEO

77/100
53
$62.6M
$13.1M
View Profile
12
Harmony Biosciences's Competitor - Takeda logo
Christophe Weber's photo - President & CEO of Takeda

Christophe Weber

President & CEO

76/100
47,099
$7.5B
$28.4B
View Profile

Missing a competitor? Contribute!

sunosi is Harmony Biosciences's biggest rival. sunosi was founded in , } in null. sunosi operates in the industry. Compared to Harmony Biosciences, sunosi generates $ less revenue.

Provigil is Harmony Biosciences's #2 rival. Provigil's headquarters is in , , and was founded in null. Provigil competes in the Health Care Services field. Provigil generates NaN% of Harmony Biosciences's revenue.

NUVIGIL is Harmony Biosciences's #3 competitor. NUVIGIL was founded in null in , . NUVIGIL operates in the industry. NUVIGIL generates $225.4M less revenue than Harmony Biosciences.

Harmony Biosciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$235.4M

Harmony Biosciences's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 3.4B. Over the last four quarters, Harmony Biosciences's revenue has grown by 61.9%. Specifically, in Q2 2021's revenue was $73.8M; in Q1 2021, it was $59.7M; in Q4 2020, it was $56.3M; in Q3 2020, Harmony Biosciences's revenue was $45.6M.

Harmony Biosciences Acquisitions

No recent acquisitions found related to Harmony Biosciences

Harmony Biosciences Funding History

Since Harmony Biosciences was founded in 2017, it has participated in 5 rounds of funding. In total Harmony Biosciences has raised $673.4M. Harmony Biosciences' last funding round was on Aug 2020 for a total of $128.4M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Aug 2020
$128.4M
-
Equity
Aug 2019
$50M
-
Debt
Mar 2019
$200M
Equity
Jan 2018
$25M
-
Equity
Sep 2017
$270M
-

Since Harmony Biosciences was founded in 2017, it has participated in 5 rounds of funding. In total Harmony Biosciences has raised $673.4M. Harmony Biosciences' last funding round was on Aug 2020 for a total of $128.4M

Harmony Biosciences Investments

No recent investments found related to Harmony Biosciences

Harmony Biosciences News

August 10, 2021Endpoints News

Paragon's Harmony Biosciences brings in $330M of debt capital and equity, looking to expand narcolepsy drug label

Jeff Aronin's Harmony Biosciences is ringing in a new financing agreement, one that's bringing in hun... See more »
August 10, 2021Citybizlist

Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates

PLYMOUTH MEETING, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) - Harmony Biosciences Holdings, Inc. (Nasdaq: H... See more »
August 10, 2021Markets Insider

Blackstone Enters Into Financing Deal With Harmony

(RTTNews) - The Blackstone Group Inc. (BX), an alternative asset manager and provider of financial ad... See more »
August 10, 2021Benzinga

Harmony Biosciences Stock Is Trading Higher On $330M Financing Deal With Blackstone, Q2 Earning Beat Estimates

Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has entered into a $330 million financing collaborati... See more »
August 9, 2021BioSpace

Harmony Biosciences Acquires Asset With Novel Mechanism Of Action For The Potential Treatment Of Narcolepsy And Other Rare Neurological Diseases

Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to ... See more »
July 29, 2021Markets Insider

John C. Jacobs, President And CEO Of Harmony Biosciences, Named An Ernst & Young (EY) Entrepreneur Of The Year 2021 Greater Philadelphia Award Winner

PLYMOUTH MEEETING, Pa., July 29, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ('Harmony') ... See more »
July 27, 2021MarketScreener

Announces Date Of Second Quarter 2021 Financial Results

(marketscreener.com) PLYMOUTH MEETING, Pa., July 27, 2021 /PRNewswire/ -- Harmony Biosciences Holding... See more »

Harmony Biosciences Press Releases

April 27, 2021PR Newswire

Harmony Biosciences To Present WAKIX (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

PLYMOUTH MEETING, Pa., April 27, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("the Compan... See more »
April 12, 2021StreetInsider

Harmony Biosciences To Present WAKIX (Pitolisant) Data At The 2021 AAN Annual Meeting

PLYMOUTH MEETING, Pa., April 12, 2021 /PRNewswire/ --Â Harmony Biosciences Holdings, Inc. ("Harmony")... See more »
June 2, 2020PR Newswire

WAKIX (pitolisant) Data From Harmony Biosciences Included on American Academy of Neurology Science Highlights Virtual Platform

/PRNewswire/ -- Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to d... See more »
April 29, 2020PR Newswire

Harmony Biosciences Recognized By Fortune As A Top Ten 2020 Best Workplace In Biopharma

PLYMOUTH MEETING, Pa., April 29, 2020 /PRNewswire/ -- Harmony Biosciences, LLC ("Harmony"), a private... See more »
April 27, 2020PR Newswire

Harmony Biosciences Expands Patients At The Heart Grant Program And Reinforces Its Commitment To Newly Uninsured Patients

PLYMOUTH MEETING, Pa., April 27, 2020 /PRNewswire/ -- Harmony Biosciences, LLC ("Harmony"), a private... See more »
March 30, 2020PR Newswire

Harmony Biosciences Highlights Publication Of Narcolepsy Treatment Scientific Review In Sleep Medicine

/PRNewswire/ -- Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to d... See more »
February 3, 2020StreetInsider

Harmony Biosciences Certified As A Great Place To Work In An Independent Survey

PLYMOUTH MEETING, Pa., Feb. 3, 2020 /PRNewswire/ --Â Harmony Biosciences, LLC ("Harmony"), a private ... See more »

Social Media

Harmony Biosciences Headquarters

630 W. Germantown Pike Suite 215

Plymouth Meeting, Pennsylvania19462

484-539-9800

Driving Directions »

Trending Companies

Harmony Biosciences Summary

ABOUT

Overview

Harmony Biosciences is a biopharmaceutical company that researches and develops novel therapeutics for patients with orphan and rare diseases. Harmony Biosciences was founded in 2017. Harmony Biosciences' headquarters is located in Plymouth Meeting, P...

CEO

Harmony Biosciences's President & CEO, John C Jacobs, currently has an approval rating of 90%. Harmony Biosciences's primary competitors are sunosi, Provigil & NUVIGIL.

Frequently Asked Questions about Harmony Biosciences

  1. When was Harmony Biosciences founded?

    Harmony Biosciences was founded in 2017
  2. Who is Harmony Biosciences's CEO?

    Harmony Biosciences's CEO is John C Jacobs
  3. How much revenue does Harmony Biosciences generate?

    Harmony Biosciences generates $235.4M in revenue
  4. How much funding does Harmony Biosciences have?

    Harmony Biosciences has historically raised $673.4M in funding
  1. Where is Harmony Biosciences's headquarters?

    Harmony Biosciences's headquarters is in Plymouth Meeting Pennsylvania, USA
  2. How many employees does Harmony Biosciences have?

    Harmony Biosciences has 150 employees
  3. What sector does Harmony Biosciences operate in?

    Harmony Biosciences is in Pharmaceuticals, Biotechnology
  4. Who are Harmony Biosciences's competitors?

    Harmony Biosciences's top competitors are sunosi, Provigil, NUVIGIL